Carna Biosciences, Inc. (TYO:4572)
Japan · Delayed Price · Currency is JPY 338.00
-1.00 (-0.29%)
Jul 16, 2026, 10:13 AM JST
Carna Biosciences Market Cap
Carna Biosciences has a market cap or net worth of 6.98 billion as of July 15, 2026. Its market cap has increased by 17.22% in one year.
Market Cap
6.98B
Enterprise Value
7.70B
Revenue
619.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
338.00
Market Cap Chart
Since March 25, 2008, Carna Biosciences's market cap has increased from 4.63B to 6.98B, an increase of 50.94%. That is a compound annual growth rate of 2.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 6.98B | 2.50% |
| Dec 30, 2025 | 6.81B | 18.93% |
| Dec 30, 2024 | 5.73B | -35.99% |
| Dec 29, 2023 | 8.95B | 21.11% |
| Dec 30, 2022 | 7.39B | -49.61% |
| Dec 30, 2021 | 14.67B | -2.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 8.36B |
| StemCell Institute | 7.89B |
| OncoTherapy Science | 7.67B |
| Kidswell Bio | 7.49B |
| ADR Biomedical Holdings | 7.19B |
| MEDINET | 7.00B |
| BrightPath Biotherapeutics | 6.94B |
| CellSource | 6.91B |